These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7883835)

  • 1. No apparent mineralocorticoid receptor defect in a series of sporadic cases of pseudohypoaldosteronism.
    Arai K; Tsigos C; Suzuki Y; Listwak S; Zachman K; Zangeneh F; Rapaport R; Chanoine JP; Chrousos GP
    J Clin Endocrinol Metab; 1995 Mar; 80(3):814-7. PubMed ID: 7883835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of amiloride-sensitive sodium channel subunits in five sporadic cases of pseudohypoaldosteronism: do they have pathologic potential?
    Arai K; Zachman K; Shibasaki T; Chrousos GP
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2434-7. PubMed ID: 10404817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy.
    Arai K; Tsigos C; Suzuki Y; Irony I; Karl M; Listwak S; Chrousos GP
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1019-23. PubMed ID: 7962269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphisms in the mineralocorticoid receptor and amirolide-sensitive sodium channel genes in a patient with sporadic pseudohypoaldosteronism.
    Arai K; Nakagomi Y; Iketani M; Shimura Y; Amemiya S; Ohyama K; Shibasaki T
    Hum Genet; 2003 Jan; 112(1):91-7. PubMed ID: 12483305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism.
    Zennaro MC; Borensztein P; Jeunemaitre X; Armanini D; Soubrier F
    J Clin Endocrinol Metab; 1994 Jul; 79(1):32-8. PubMed ID: 8027248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudohypoaldosteronism: molecular characterization of the mineralocorticoid receptor.
    Komesaroff PA; Verity K; Fuller PJ
    J Clin Endocrinol Metab; 1994 Jul; 79(1):27-31. PubMed ID: 8027241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
    Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
    Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC
    Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
    Geller DS; Rodriguez-Soriano J; Vallo Boado A; Schifter S; Bayer M; Chang SS; Lifton RP
    Nat Genet; 1998 Jul; 19(3):279-81. PubMed ID: 9662404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic disorders caused by gain or loss of function of the mineralocorticoid receptor].
    Arai K; Shibasaki T
    Nihon Rinsho; 2002 Feb; 60(2):361-6. PubMed ID: 11857927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene.
    Fernandes-Rosa FL; de Castro M; Latronico AC; Sippell WG; Riepe FG; Antonini SR
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3671-5. PubMed ID: 16757525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of the mineralocorticoid receptor in pseudohypoaldosteronism.
    Zennaro MC; Borensztein P; Jeunemaitre X; Armanini D; Corvol P; Soubrier F
    Steroids; 1995 Jan; 60(1):164-7. PubMed ID: 7792806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudohypoaldosteronism due to renal and multisystem resistance to mineralocorticoids respond differently to carbenoxolone.
    Hanukoglu A; Joy O; Steinitz M; Rosler A; Hanukoglu I
    J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):105-12. PubMed ID: 9182864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid resistance.
    Zennaro MC; Lombès M
    Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel nonsense mutation of the mineralocorticoid receptor gene in a Swedish family with pseudohypoaldosteronism type I (PHA1).
    Nyström AM; Bondeson ML; Skanke N; Mårtensson J; Strömberg B; Gustafsson J; Annerén G
    J Clin Endocrinol Metab; 2004 Jan; 89(1):227-31. PubMed ID: 14715854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pseudohypoaldosteronism].
    Arai K; Naruse K; Tanabe A; Naruse M; Demura H
    Nihon Rinsho; 1996 Mar; 54(3):812-8. PubMed ID: 8904242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.
    Riepe FG; Finkeldei J; de Sanctis L; Einaudi S; Testa A; Karges B; Peter M; Viemann M; Grötzinger J; Sippell WG; Fejes-Toth G; Krone N
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4552-61. PubMed ID: 16954160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds.
    Viemann M; Peter M; López-Siguero JP; Simic-Schleicher G; Sippell WG
    J Clin Endocrinol Metab; 2001 May; 86(5):2056-9. PubMed ID: 11344206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal-dominant pseudohypoaldosteronism type 1 in a Turkish family is associated with a novel nonsense mutation in the human mineralocorticoid receptor gene.
    Riepe FG; Krone N; Morlot M; Peter M; Sippell WG; Partsch CJ
    J Clin Endocrinol Metab; 2004 May; 89(5):2150-2. PubMed ID: 15126534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism.
    Sartorato P; Lapeyraque AL; Armanini D; Kuhnle U; Khaldi Y; Salomon R; Abadie V; Di Battista E; Naselli A; Racine A; Bosio M; Caprio M; Poulet-Young V; Chabrolle JP; Niaudet P; De Gennes C; Lecornec MH; Poisson E; Fusco AM; Loli P; Lombès M; Zennaro MC
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2508-17. PubMed ID: 12788847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.